Starting from 1 November 2014, companies will be allowed to apply for conditional marketing approval in Japan. The key requirement, for companies from all around the world willing to benefit from this accelerated path to market, is to provide data from a clinical study predicting likely efficacy and confirm short-time safety.
http://www.totalbiopharma.com/2014/...apans-new-legislation-will-companies-benefit/
Listening to last months webcast there was some mention about November 2014 and the regulatory framework for Japan being clearly outlined by the authorities.
Outside of the JCR alliance , MSB have had 12 months to prepare for the start date of new Japan regulations...I'm thinking the team at Meso would be aware of this date.
Could be one of the major turning points in the company.
My opinion only. Please DYOR.
Good luck to all holders.
- Forums
- ASX - By Stock
- MSB
- Japan Regulations
Japan Regulations
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.06 |
Change
-0.065(5.78%) |
Mkt cap ! $1.255B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.06 | $7.816M | 7.117M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 97385 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 39747 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5776 | 1.070 |
18 | 161559 | 1.065 |
23 | 289780 | 1.060 |
14 | 137241 | 1.055 |
19 | 697836 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 104229 | 17 |
1.080 | 130786 | 14 |
1.085 | 194016 | 13 |
1.090 | 53365 | 6 |
1.095 | 55724 | 4 |
Last trade - 15.41pm 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |